Ayala Pharmaceuticals AYLA

$ 0.5 0.0%

Annual report 2022
added 03-31-2023

Ayala Pharmaceuticals Balance Sheet 2011-2024 | AYLA

Annual Balance Sheet Ayala Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-657 K	-	-41.5 M	-16.4 M	-26.1 M	-	-	-	-	-	-	-
Long Term Debt	1.33 M	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	419 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	553 K	299 K	46.2 M	-	-	-	-	-	-	-
Total Current Liabilities	7.54 M	6.47 M	6.88 M	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	7.43 M	5.6 M	49 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-149 M	-111 M	-70.9 M	-40.7 M	-22.9 M	-	-	-	-	-	-	-
Total Assets	7.77 M	41.1 M	45.8 M	20.1 M	27.1 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	2.41 M	37 M	42 M	16.8 M	-	-	-	-	-	-	-	-
Book Value	7.77 M	41.1 M	38.4 M	14.5 M	-21.9 M	-	-	-	-	-	-	-
Total Shareholders Equity	-1.1 M	34.2 M	38.4 M	-38.9 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Ayala Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	396 K	414 K	472 K	497 K	493 K	502 K	505 K	553 K	553 K	553 K	553 K	299 K	299 K	299 K	299 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-140 M	-129 M	-121 M	-111 M	-101 M	-91.3 M	-80.5 M	-70.9 M	-70.9 M	-70.9 M	-70.9 M	-40.7 M	-40.7 M	-40.7 M	-40.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	14.3 M	24 M	30.6 M	41.1 M	45.7 M	48.5 M	59.2 M	45.8 M	45.8 M	45.8 M	45.8 M	20.1 M	20.1 M	20.1 M	20.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	11.2 M	20.1 M	27 M	37 M	41.2 M	44.8 M	56 M	42 M	42 M	42 M	42 M	16.7 M	16.7 M	16.7 M	16.7 M	26.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	14.3 M	24 M	30.6 M	41.1 M	45.7 M	48.5 M	59.2 M	45.8 M	45.8 M	45.8 M	45.8 M	20.1 M	20.1 M	20.1 M	20.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	8.16 M	17.4 M	24.8 M	34.2 M	39.4 M	42.8 M	53 M	38.4 M	38.4 M	38.4 M	38.4 M	-38.9 M	-38.9 M	-38.9 M	-38.9 M	-21.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency